APO Research
Talk to an analyst

APO RESEARCH · REPORT

At-Home Health Testing Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global At-Home Health Testing Solutions Market Outlook and Growth Opportunities 2026

21 December 2025205 pages

Choose your research edition.

Industry ResearchAt-Home Health Testing Solutions Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal At-Home Health Testing Solutions Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal At-Home Health Testing Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal At-Home Health Testing Solutions Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal At-Home Health Testing Solutions Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global At-Home Health Testing Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for At-Home Health Testing Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for At-Home Health Testing Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for At-Home Health Testing Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the At-Home Health Testing Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the At-Home Health Testing Solutions market include New Horizon Health Limited, Test Onelife, Creative Biosciences (Guangzhou), AnDall, Everlywell, Modern Fertility, 23andMe, Cue Health and LetsGetChecked, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global At-Home Health Testing Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of At-Home Health Testing Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents At-Home Health Testing Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global At-Home Health Testing Solutions market.

At-Home Health Testing Solutions Segment by Company

New Horizon Health Limited

Test Onelife

Creative Biosciences (Guangzhou)

AnDall

Everlywell

Modern Fertility

23andMe

Cue Health

LetsGetChecked

ixlayer

Pixel by LabCorp

Thriva

MyLab Box

Ash

Viome

SiPhox Health

TytoCare

Randox Health

Nurx

At-Home Health Testing Solutions Segment by Type

Blood Testing

Urine Testing

Others

At-Home Health Testing Solutions Segment by Application

Consumer-Grade Diagnostics

Clinical Grade Diagnosis

At-Home Health Testing Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global At-Home Health Testing Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the At-Home Health Testing Solutions key companies, revenue, market share, and recent developments.

3. To split the At-Home Health Testing Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions At-Home Health Testing Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify At-Home Health Testing Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze At-Home Health Testing Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global At-Home Health Testing Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of At-Home Health Testing Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of At-Home Health Testing Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global At-Home Health Testing Solutions industry.

Chapter 3: Detailed analysis of At-Home Health Testing Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of At-Home Health Testing Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of At-Home Health Testing Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. At-Home Health Testing Solutions Industry Trends Table 2. At-Home Health Testing Solutions Industry Drivers Table 3. At-Home Health Testing Solutions Industry Opportunities and Challenges Table 4. At-Home Health Testing Solutions Industry Restraints Table 5. Global At-Home Health Testing Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global At-Home Health Testing Solutions Revenue Share by Company (2021-2026) Table 7. Global At-Home Health Testing Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global At-Home Health Testing Solutions Key Company Manufacturing Base & Headquarters Table 9. Global At-Home Health Testing Solutions Company, Product Type & Application Table 10. Global At-Home Health Testing Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global At-Home Health Testing Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Blood Testing Table 15. Significant Companies of Urine Testing Table 16. Significant Companies of Others Table 17. Global At-Home Health Testing Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global At-Home Health Testing Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global At-Home Health Testing Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global At-Home Health Testing Solutions Sales Value Share by Type (2021-2026) Table 21. Global At-Home Health Testing Solutions Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Consumer-Grade Diagnostics Table 23. Significant Companies of Clinical Grade Diagnosis Table 24. Global At-Home Health Testing Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global At-Home Health Testing Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global At-Home Health Testing Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global At-Home Health Testing Solutions Sales Value Share by Application (2021-2026) Table 28. Global At-Home Health Testing Solutions Sales Value Share by Application (2027-2032) Table 29. Global At-Home Health Testing Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global At-Home Health Testing Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global At-Home Health Testing Solutions Sales Value Share by Region (2021-2026) Table 32. Global At-Home Health Testing Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global At-Home Health Testing Solutions Sales Value Share by Region (2027-2032) Table 34. Global At-Home Health Testing Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global At-Home Health Testing Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global At-Home Health Testing Solutions Sales Value Market Share by Country (2021-2026) Table 37. Global At-Home Health Testing Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global At-Home Health Testing Solutions Sales Value Market Share by Country (2027-2032) Table 39. New Horizon Health Limited Company Information Table 40. New Horizon Health Limited Business Overview Table 41. New Horizon Health Limited At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. New Horizon Health Limited At-Home Health Testing Solutions Product Portfolio Table 43. New Horizon Health Limited Recent Development Table 44. Test Onelife Company Information Table 45. Test Onelife Business Overview Table 46. Test Onelife At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Test Onelife At-Home Health Testing Solutions Product Portfolio Table 48. Test Onelife Recent Development Table 49. Creative Biosciences (Guangzhou) Company Information Table 50. Creative Biosciences (Guangzhou) Business Overview Table 51. Creative Biosciences (Guangzhou) At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Creative Biosciences (Guangzhou) At-Home Health Testing Solutions Product Portfolio Table 53. Creative Biosciences (Guangzhou) Recent Development Table 54. AnDall Company Information Table 55. AnDall Business Overview Table 56. AnDall At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. AnDall At-Home Health Testing Solutions Product Portfolio Table 58. AnDall Recent Development Table 59. Everlywell Company Information Table 60. Everlywell Business Overview Table 61. Everlywell At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Everlywell At-Home Health Testing Solutions Product Portfolio Table 63. Everlywell Recent Development Table 64. Modern Fertility Company Information Table 65. Modern Fertility Business Overview Table 66. Modern Fertility At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Modern Fertility At-Home Health Testing Solutions Product Portfolio Table 68. Modern Fertility Recent Development Table 69. 23andMe Company Information Table 70. 23andMe Business Overview Table 71. 23andMe At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. 23andMe At-Home Health Testing Solutions Product Portfolio Table 73. 23andMe Recent Development Table 74. Cue Health Company Information Table 75. Cue Health Business Overview Table 76. Cue Health At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cue Health At-Home Health Testing Solutions Product Portfolio Table 78. Cue Health Recent Development Table 79. LetsGetChecked Company Information Table 80. LetsGetChecked Business Overview Table 81. LetsGetChecked At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. LetsGetChecked At-Home Health Testing Solutions Product Portfolio Table 83. LetsGetChecked Recent Development Table 84. ixlayer Company Information Table 85. ixlayer Business Overview Table 86. ixlayer At-Home Health Testing Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ixlayer At-Home Health Testing Solutions Product Portfolio Table 88. ixlayer Recent Development Table 89. Pixel by LabCorp Company Information Table 90. Pixel by LabCorp Business Overview Table 91. Pixel by LabCorp At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Pixel by LabCorp At-Home Health Testing Solutions Product Portfolio Table 93. Pixel by LabCorp Recent Development Table 94. Thriva Company Information Table 95. Thriva Business Overview Table 96. Thriva At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Thriva At-Home Health Testing Solutions Product Portfolio Table 98. Thriva Recent Development Table 99. MyLab Box Company Information Table 100. MyLab Box Business Overview Table 101. MyLab Box At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. MyLab Box At-Home Health Testing Solutions Product Portfolio Table 103. MyLab Box Recent Development Table 104. Ash Company Information Table 105. Ash Business Overview Table 106. Ash At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Ash At-Home Health Testing Solutions Product Portfolio Table 108. Ash Recent Development Table 109. Viome Company Information Table 110. Viome Business Overview Table 111. Viome At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Viome At-Home Health Testing Solutions Product Portfolio Table 113. Viome Recent Development Table 114. SiPhox Health Company Information Table 115. SiPhox Health Business Overview Table 116. SiPhox Health At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. SiPhox Health At-Home Health Testing Solutions Product Portfolio Table 118. SiPhox Health Recent Development Table 119. TytoCare Company Information Table 120. TytoCare Business Overview Table 121. TytoCare At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. TytoCare At-Home Health Testing Solutions Product Portfolio Table 123. TytoCare Recent Development Table 124. Randox Health Company Information Table 125. Randox Health Business Overview Table 126. Randox Health At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Randox Health At-Home Health Testing Solutions Product Portfolio Table 128. Randox Health Recent Development Table 129. Nurx Company Information Table 130. Nurx Business Overview Table 131. Nurx At-Home Health Testing Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Nurx At-Home Health Testing Solutions Product Portfolio Table 133. Nurx Recent Development Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. At-Home Health Testing Solutions Product Image Figure 2. Global At-Home Health Testing Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global At-Home Health Testing Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global At-Home Health Testing Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Blood Testing Image Figure 8. Urine Testing Image Figure 9. Others Image Figure 10. Global At-Home Health Testing Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global At-Home Health Testing Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global At-Home Health Testing Solutions Sales Value Share by Type (2021-2032) Figure 13. Consumer-Grade Diagnostics Image Figure 14. Clinical Grade Diagnosis Image Figure 15. Global At-Home Health Testing Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global At-Home Health Testing Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global At-Home Health Testing Solutions Sales Value Share by Application (2021-2032) Figure 18. Global At-Home Health Testing Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global At-Home Health Testing Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America At-Home Health Testing Solutions Sales Value (2021-2032) & (US$ Million) Figure 21. North America At-Home Health Testing Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe At-Home Health Testing Solutions Sales Value (2021-2032) & (US$ Million) Figure 23. Europe At-Home Health Testing Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific At-Home Health Testing Solutions Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific At-Home Health Testing Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America At-Home Health Testing Solutions Sales Value (2021-2032) & (US$ Million) Figure 27. South America At-Home Health Testing Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa At-Home Health Testing Solutions Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa At-Home Health Testing Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Testing
  • Urine Testing
  • Others
Applications
  • Consumer-Grade Diagnostics
  • Clinical Grade Diagnosis
Companies covered
  • New Horizon Health Limited
  • Test Onelife
  • Creative Biosciences (Guangzhou)
  • AnDall
  • Everlywell
  • Modern Fertility
  • 23andMe
  • Cue Health
  • LetsGetChecked
  • ixlayer
  • Pixel by LabCorp
  • Thriva
  • MyLab Box
  • Ash
  • Viome
  • SiPhox Health
  • TytoCare
  • Randox Health
  • Nurx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global At-Home Health Testing Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global At-Home Health Testing Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 At-Home Health Testing Solutions Market Dynamics
  1. 2.1 At-Home Health Testing Solutions Industry Trends
  2. 2.2 At-Home Health Testing Solutions Industry Drivers
  3. 2.3 At-Home Health Testing Solutions Industry Opportunities and Challenges
  4. 2.4 At-Home Health Testing Solutions Industry Restraints
3 At-Home Health Testing Solutions Market by Company
  1. 3.1 Global At-Home Health Testing Solutions Company Revenue Ranking in 2025
  2. 3.2 Global At-Home Health Testing Solutions Revenue by Company (2021-2026)
  3. 3.3 Global At-Home Health Testing Solutions Company Ranking (2024-2026)
  4. 3.4 Global At-Home Health Testing Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global At-Home Health Testing Solutions Company Product Type and Application
  6. 3.6 Global At-Home Health Testing Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global At-Home Health Testing Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 At-Home Health Testing Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 At-Home Health Testing Solutions Market by Type
  1. 4.1 At-Home Health Testing Solutions Type Introduction
  2. 4.1.1 Blood Testing
  3. 4.1.2 Urine Testing
  4. 4.1.3 Others
  5. 4.2 Global At-Home Health Testing Solutions Sales Value by Type
  6. 4.2.1 Global At-Home Health Testing Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global At-Home Health Testing Solutions Sales Value by Type (2021-2032)
  8. 4.2.3 Global At-Home Health Testing Solutions Sales Value Share by Type (2021-2032)
5 At-Home Health Testing Solutions Market by Application
  1. 5.1 At-Home Health Testing Solutions Application Introduction
  2. 5.1.1 Consumer-Grade Diagnostics
  3. 5.1.2 Clinical Grade Diagnosis
  4. 5.2 Global At-Home Health Testing Solutions Sales Value by Application
  5. 5.2.1 Global At-Home Health Testing Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global At-Home Health Testing Solutions Sales Value by Application (2021-2032)
  7. 5.2.3 Global At-Home Health Testing Solutions Sales Value Share by Application (2021-2032)
6 At-Home Health Testing Solutions Regional Value Analysis
  1. 6.1 Global At-Home Health Testing Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global At-Home Health Testing Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global At-Home Health Testing Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global At-Home Health Testing Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America At-Home Health Testing Solutions Sales Value (2021-2032)
  7. 6.3.2 North America At-Home Health Testing Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe At-Home Health Testing Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe At-Home Health Testing Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific At-Home Health Testing Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific At-Home Health Testing Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America At-Home Health Testing Solutions Sales Value (2021-2032)
  16. 6.6.2 South America At-Home Health Testing Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa At-Home Health Testing Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa At-Home Health Testing Solutions Sales Value Share by Country, 2025 VS 2032
7 At-Home Health Testing Solutions Country-level Value Analysis
  1. 7.1 Global At-Home Health Testing Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global At-Home Health Testing Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global At-Home Health Testing Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global At-Home Health Testing Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt At-Home Health Testing Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt At-Home Health Testing Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt At-Home Health Testing Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 New Horizon Health Limited
  2. 8.1.1 New Horizon Health Limited Company Information
  3. 8.1.2 New Horizon Health Limited Business Overview
  4. 8.1.3 New Horizon Health Limited At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 New Horizon Health Limited At-Home Health Testing Solutions Product Portfolio
  6. 8.1.5 New Horizon Health Limited Recent Developments
  7. 8.2 Test Onelife
  8. 8.2.1 Test Onelife Company Information
  9. 8.2.2 Test Onelife Business Overview
  10. 8.2.3 Test Onelife At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Test Onelife At-Home Health Testing Solutions Product Portfolio
  12. 8.2.5 Test Onelife Recent Developments
  13. 8.3 Creative Biosciences (Guangzhou)
  14. 8.3.1 Creative Biosciences (Guangzhou) Company Information
  15. 8.3.2 Creative Biosciences (Guangzhou) Business Overview
  16. 8.3.3 Creative Biosciences (Guangzhou) At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Creative Biosciences (Guangzhou) At-Home Health Testing Solutions Product Portfolio
  18. 8.3.5 Creative Biosciences (Guangzhou) Recent Developments
  19. 8.4 AnDall
  20. 8.4.1 AnDall Company Information
  21. 8.4.2 AnDall Business Overview
  22. 8.4.3 AnDall At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AnDall At-Home Health Testing Solutions Product Portfolio
  24. 8.4.5 AnDall Recent Developments
  25. 8.5 Everlywell
  26. 8.5.1 Everlywell Company Information
  27. 8.5.2 Everlywell Business Overview
  28. 8.5.3 Everlywell At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Everlywell At-Home Health Testing Solutions Product Portfolio
  30. 8.5.5 Everlywell Recent Developments
  31. 8.6 Modern Fertility
  32. 8.6.1 Modern Fertility Company Information
  33. 8.6.2 Modern Fertility Business Overview
  34. 8.6.3 Modern Fertility At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Modern Fertility At-Home Health Testing Solutions Product Portfolio
  36. 8.6.5 Modern Fertility Recent Developments
  37. 8.7 23andMe
  38. 8.7.1 23andMe Company Information
  39. 8.7.2 23andMe Business Overview
  40. 8.7.3 23andMe At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 23andMe At-Home Health Testing Solutions Product Portfolio
  42. 8.7.5 23andMe Recent Developments
  43. 8.8 Cue Health
  44. 8.8.1 Cue Health Company Information
  45. 8.8.2 Cue Health Business Overview
  46. 8.8.3 Cue Health At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cue Health At-Home Health Testing Solutions Product Portfolio
  48. 8.8.5 Cue Health Recent Developments
  49. 8.9 LetsGetChecked
  50. 8.9.1 LetsGetChecked Company Information
  51. 8.9.2 LetsGetChecked Business Overview
  52. 8.9.3 LetsGetChecked At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LetsGetChecked At-Home Health Testing Solutions Product Portfolio
  54. 8.9.5 LetsGetChecked Recent Developments
  55. 8.10 ixlayer
  56. 8.10.1 ixlayer Company Information
  57. 8.10.2 ixlayer Business Overview
  58. 8.10.3 ixlayer At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ixlayer At-Home Health Testing Solutions Product Portfolio
  60. 8.10.5 ixlayer Recent Developments
  61. 8.11 Pixel by LabCorp
  62. 8.11.1 Pixel by LabCorp Company Information
  63. 8.11.2 Pixel by LabCorp Business Overview
  64. 8.11.3 Pixel by LabCorp At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pixel by LabCorp At-Home Health Testing Solutions Product Portfolio
  66. 8.11.5 Pixel by LabCorp Recent Developments
  67. 8.12 Thriva
  68. 8.12.1 Thriva Company Information
  69. 8.12.2 Thriva Business Overview
  70. 8.12.3 Thriva At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thriva At-Home Health Testing Solutions Product Portfolio
  72. 8.12.5 Thriva Recent Developments
  73. 8.13 MyLab Box
  74. 8.13.1 MyLab Box Company Information
  75. 8.13.2 MyLab Box Business Overview
  76. 8.13.3 MyLab Box At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MyLab Box At-Home Health Testing Solutions Product Portfolio
  78. 8.13.5 MyLab Box Recent Developments
  79. 8.14 Ash
  80. 8.14.1 Ash Company Information
  81. 8.14.2 Ash Business Overview
  82. 8.14.3 Ash At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ash At-Home Health Testing Solutions Product Portfolio
  84. 8.14.5 Ash Recent Developments
  85. 8.15 Viome
  86. 8.15.1 Viome Company Information
  87. 8.15.2 Viome Business Overview
  88. 8.15.3 Viome At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Viome At-Home Health Testing Solutions Product Portfolio
  90. 8.15.5 Viome Recent Developments
  91. 8.16 SiPhox Health
  92. 8.16.1 SiPhox Health Company Information
  93. 8.16.2 SiPhox Health Business Overview
  94. 8.16.3 SiPhox Health At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 SiPhox Health At-Home Health Testing Solutions Product Portfolio
  96. 8.16.5 SiPhox Health Recent Developments
  97. 8.17 TytoCare
  98. 8.17.1 TytoCare Company Information
  99. 8.17.2 TytoCare Business Overview
  100. 8.17.3 TytoCare At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 TytoCare At-Home Health Testing Solutions Product Portfolio
  102. 8.17.5 TytoCare Recent Developments
  103. 8.18 Randox Health
  104. 8.18.1 Randox Health Company Information
  105. 8.18.2 Randox Health Business Overview
  106. 8.18.3 Randox Health At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Randox Health At-Home Health Testing Solutions Product Portfolio
  108. 8.18.5 Randox Health Recent Developments
  109. 8.19 Nurx
  110. 8.19.1 Nurx Company Information
  111. 8.19.2 Nurx Business Overview
  112. 8.19.3 Nurx At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Nurx At-Home Health Testing Solutions Product Portfolio
  114. 8.19.5 Nurx Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst